Startups
Our mission is to help oncologists select the most effective treatment for patients with cancer in the bone. Leveraging 3D bioprinting technology, we recreate the unique cancerous condition of the patient's bone in a controlled laboratory environment, enabling us to assess different drug reactions and determine personalized treatment options. By surpassing the limitations of conventional animal and 2D models, we also envision our solution as a powerful tool for drug development, accurately reproducing human physiological conditions and driving innovation in the field. Together, we aim to revolutionize cancer treatment by offering personalized solutions that improve patient outcomes and advance the field of oncology.
Overview
Employees
1-10
Total raised
$43.3K
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 29, 2022 | CHF 40,000 for a 3D fitting algorithm for online shoppers, a personal metabolic health analysis platform, and a novel rehabilitation system | Alter Ego: a 3D fitting algorithm for online shoppers When buying clothes online, most customers are uncertain about the size that would fit them. Hence, 30% of the ordered articles are returned, and handling these operations costs up to 30... |
| Aug 11, 2022 | Startup developing a safe laser powder bed fusion machine, a plastic action and circular economy platform, drug therapies for bone health, a personal metabolic health analysis platform, and an autonomous vineyard vehicle each win CHF 10,000 | a-metal: Making metal 3d printing more accessible to the broad industry Today, there are many obstacles for SMEs or inexperienced enterprises to get into additive manufacturing technologies. Especially for metal-based AM technologies, machi... |
| CompagOs | “Compagos personalizes treatment for cancer in bone using 3D-printed bone organoids.” |
Reviews 0
FAQ about CompagOs
How much funding has CompagOs raised?
CompagOs has raised $43.3K in total across 1 funding round.
What has the press written about CompagOs?
Parsers VC has collected 4 articles mentioning CompagOs, among them “CHF 40,000 for a 3D fitting algorithm for online shoppers, a personal metabolic health analysis platform, and a novel rehabilitation system” (Nov 29, 2022) and “Startup developing a safe laser powder bed fusion machine, a plastic action and circular economy platform, drug therapies for bone health, a personal metabol...” (Aug 11, 2022).
Is CompagOs still active?
Yes, CompagOs is active; its latest activity on Parsers VC dates from Jun 29, 2023.